Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of 194.81 billion. The enterprise value is 212.11 billion.
| Market Cap | 194.81B |
| Enterprise Value | 212.11B |
Important Dates
The next estimated earnings date is Friday, January 31, 2025.
| Earnings Date | Jan 31, 2025 |
| Ex-Dividend Date | Oct 4, 2023 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.91% |
| Shares Change (QoQ) | -0.93% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.91B |
Valuation Ratios
The trailing PE ratio is 11.07.
| PE Ratio | 11.07 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.66, with an EV/FCF ratio of 14.37.
| EV / Earnings | 12.05 |
| EV / Sales | 4.52 |
| EV / EBITDA | 10.66 |
| EV / EBIT | 12.36 |
| EV / FCF | 14.37 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.74.
| Current Ratio | 1.11 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.74 |
| Debt / EBITDA | 1.51 |
| Debt / FCF | 2.18 |
| Interest Coverage | 19.33 |
Financial Efficiency
Return on equity (ROE) is 28.79% and return on invested capital (ROIC) is 16.47%.
| Return on Equity (ROE) | 28.79% |
| Return on Assets (ROA) | 10.59% |
| Return on Capital (ROIC) | 16.47% |
| Revenue Per Employee | 656,613 |
| Profits Per Employee | 231,445 |
| Employee Count | 76,057 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 2.09 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.35% in the last 52 weeks. The beta is 0.50, so Novartis AG's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -3.35% |
| 50-Day Moving Average | 104.01 |
| 200-Day Moving Average | 104.50 |
| Relative Strength Index (RSI) | 44.13 |
| Average Volume (20 Days) | 12,125 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis AG had revenue of 49.94 billion and earned 17.60 billion in profits. Earnings per share was 8.58.
| Revenue | 49.94B |
| Gross Profit | 37.87B |
| Operating Income | 18.32B |
| Pretax Income | 12.73B |
| Net Income | 17.60B |
| EBITDA | 20.99B |
| EBIT | 18.32B |
| Earnings Per Share (EPS) | 8.58 |
Balance Sheet
The company has 13.85 billion in cash and 32.16 billion in debt, giving a net cash position of -18.31 billion.
| Cash & Cash Equivalents | 13.85B |
| Total Debt | 32.16B |
| Net Cash | -18.31B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 43.44B |
| Book Value Per Share | 21.67 |
| Working Capital | 3.13B |
Cash Flow
In the last 12 months, operating cash flow was 15.97 billion and capital expenditures -1.21 billion, giving a free cash flow of 14.76 billion.
| Operating Cash Flow | 15.97B |
| Capital Expenditures | -1.21B |
| Free Cash Flow | 14.76B |
| FCF Per Share | n/a |
Margins
Gross margin is 75.83%, with operating and profit margins of 36.69% and 35.25%.
| Gross Margin | 75.83% |
| Operating Margin | 36.69% |
| Pretax Margin | 25.49% |
| Profit Margin | 35.25% |
| EBITDA Margin | 42.02% |
| EBIT Margin | 36.69% |
| FCF Margin | 29.55% |
Dividends & Yields
This stock pays an annual dividend of 5.23, which amounts to a dividend yield of 4.75%.
| Dividend Per Share | 5.23 |
| Dividend Yield | 4.75% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 43.31% |
| Buyback Yield | 2.91% |
| Shareholder Yield | 7.66% |
| Earnings Yield | 8.77% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Novartis AG has an Altman Z-Score of 3.85.
| Altman Z-Score | 3.85 |
| Piotroski F-Score | n/a |